These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
328 related articles for article (PubMed ID: 32468469)
41. Role of miRNAs in Neurodegeneration: From Disease Cause to Tools of Biomarker Discovery and Therapeutics. Roy B; Lee E; Li T; Rampersaud M Genes (Basel); 2022 Feb; 13(3):. PubMed ID: 35327979 [TBL] [Abstract][Full Text] [Related]
42. Extracellular vesicles and Alzheimer's disease in the novel era of Precision Medicine: implications for disease progression, diagnosis and treatment. Gomes P; Tzouanou F; Skolariki K; Vamvaka-Iakovou A; Noguera-Ortiz C; Tsirtsaki K; Waites CL; Vlamos P; Sousa N; Costa-Silva B; Kapogiannis D; Sotiropoulos I Exp Neurol; 2022 Dec; 358():114183. PubMed ID: 35952764 [TBL] [Abstract][Full Text] [Related]
47. Exosomes for neurodegenerative diseases: diagnosis and targeted therapy. Tao H; Gao B J Neurol; 2024 Jun; 271(6):3050-3062. PubMed ID: 38605227 [TBL] [Abstract][Full Text] [Related]
48. Insights Into the Proteomic Profiling of Extracellular Vesicles for the Identification of Early Biomarkers of Neurodegeneration. Quiroz-Baez R; Hernández-Ortega K; Martínez-Martínez E Front Neurol; 2020; 11():580030. PubMed ID: 33362690 [TBL] [Abstract][Full Text] [Related]
49. Urinary extracellular microvesicles: isolation methods and prospects for urinary proteome. Wang D; Sun W Proteomics; 2014 Aug; 14(16):1922-32. PubMed ID: 24962155 [TBL] [Abstract][Full Text] [Related]
50. The Exosome Total Isolation Chip. Liu F; Vermesh O; Mani V; Ge TJ; Madsen SJ; Sabour A; Hsu EC; Gowrishankar G; Kanada M; Jokerst JV; Sierra RG; Chang E; Lau K; Sridhar K; Bermudez A; Pitteri SJ; Stoyanova T; Sinclair R; Nair VS; Gambhir SS; Demirci U ACS Nano; 2017 Nov; 11(11):10712-10723. PubMed ID: 29090896 [TBL] [Abstract][Full Text] [Related]
51. Endo-lysosomal dysfunction in neurodegenerative diseases: opinion on current progress and future direction in the use of exosomes as biomarkers. Herman M; Randall GW; Spiegel JL; Maldonado DJ; Simoes S Philos Trans R Soc Lond B Biol Sci; 2024 Apr; 379(1899):20220387. PubMed ID: 38368936 [TBL] [Abstract][Full Text] [Related]
52. Novel Exosome Biomarker Candidates for Alzheimer's Disease Unravelled Through Mass Spectrometry Analysis. Soares Martins T; Marçalo R; da Cruz E Silva CB; Trindade D; Catita J; Amado F; Melo T; Rosa IM; Vogelgsang J; Wiltfang J; da Cruz E Silva OAB; Henriques AG Mol Neurobiol; 2022 May; 59(5):2838-2854. PubMed ID: 35212939 [TBL] [Abstract][Full Text] [Related]
53. The use of proteomics in biomarker discovery in neurodegenerative diseases. Davidsson P; Sjögren M Dis Markers; 2005; 21(2):81-92. PubMed ID: 15920295 [TBL] [Abstract][Full Text] [Related]
54. Ascent of atomic force microscopy as a nanoanalytical tool for exosomes and other extracellular vesicles. Sharma S; LeClaire M; Gimzewski JK Nanotechnology; 2018 Apr; 29(13):132001. PubMed ID: 29376505 [TBL] [Abstract][Full Text] [Related]
55. Extracellular vesicles--Their role in the packaging and spread of misfolded proteins associated with neurodegenerative diseases. Coleman BM; Hill AF Semin Cell Dev Biol; 2015 Apr; 40():89-96. PubMed ID: 25704308 [TBL] [Abstract][Full Text] [Related]
56. Blood-based CNS regionally and neuronally enriched extracellular vesicles carrying pTau217 for Alzheimer's disease diagnosis and differential diagnosis. Guo Z; Tian C; Shi Y; Song XR; Yin W; Tao QQ; Liu J; Peng GP; Wu ZY; Wang YJ; Zhang ZX; Zhang J Acta Neuropathol Commun; 2024 Mar; 12(1):38. PubMed ID: 38444036 [TBL] [Abstract][Full Text] [Related]
57. Exosomes in Alzheimer's Disease: From Being Pathological Players to Potential Diagnostics and Therapeutics. Soliman HM; Ghonaim GA; Gharib SM; Chopra H; Farag AK; Hassanin MH; Nagah A; Emad-Eldin M; Hashem NE; Yahya G; Emam SE; Hassan AEA; Attia MS Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639135 [TBL] [Abstract][Full Text] [Related]